Evaluation of onychomycosis among diabetic patients of Yazd diabetic center
Keywords:
Diabetes mellitus, onychomycosis, YazdAbstract
Background The population suffering from diabetes is increasing all over the world. In Iran, the prevalence of diabetes is reported from 5 to 8 percent and the highest figure is for Yazd and Booshehr Province. In diabetic patients infections of nail and skin pose a great danger. Objective To determine the prevalence of onychomycosis in diabetic patients and its relation with age, gender, period of diabetes and its control. Patients and methods This descriptive study involved 262 diabetic type 2 patients which were referred to the Yazd diabetic clinic during years of 2008 to 2009. All the patients were examined by a dermatologist and the patients with clinical doubt were sent for the laboratory tests i.e. smear and culture. Confirmed cases of onychomycosis were treated with terbinafine 250mg/day for four months. The patients were followed up clinically every month and data were recorded. In the end of treatment protocol, direct smear and culture from nails was taken. Results 262 diabetic patients (123 men and 139 women) were examined. The mean age of patients and diabetic duration were 59.12 ±10.96 years and 7.24±12.8 years, respectively .Onychomycosis was diagnosed clinically in 18 patients (6.9%) and proved by culture only in 10 patients (3.8%). 70% of onychomycosis cases were men and 60% were over 60 years old. No significant relation was found between the frequency of onychomycosis and the diabetic duration but in the patients having a weaker control of diabetes onychomycosis was more frequent. Conclusion The frequency of onychomycosis in diabetic patients type 2 is 3.8% and it had a significant relation with the weak control of diabetes.ÂReferences
Bild DE, Selby JV, Sinnock P et al. Lower extremity amputation in people with diabetes epidemiology and prevention. Diabetes Care 1999; 12: 24-31.
Higa M. Clincal epidemiology of fungal Infection in diabetes. Nippon Rinsho. 2008; 66: 2239-44.
Mayser P, Freund V, Budihardja D. Toenail onychomycosis in diabetic patients: issue and management. Am J Clin Dermatol 2009; 10: 211-20.
Crawford F, Inkster M, Kleiyneny J, Fahey T. Predicting foot ulcer in patients with diabetes: a systematic review and meta analysis. QJM 2007; 100: 65-86.
Dumont IJ. Diagnosis and prevalence of onychomycosis in diabetic neuropathic an observational study. J Am Podiatr Med Assoc 2009; 99: 135-9.
Chang SJ, Hsu SC, Tien KJ et al. Metabolic syndrome associated with toenail onychomycosis in Taiwanese with diabetes mellitus. Int J Dermatol 2008; 47: 467-72.
Manzano-Gayosso P, Hernández-Hernández F, Méndez-Tovar LJ et al. Onychomycosis incidence in type 2 diabetes mellitus patients. Mycopathologia 2008; 166: 41-5.
Saunte DM, Holgersen JB, Haedersdal M et al. Prevalence of toe nail onychomycosis in diabetic patients. Acta Derm Venereol 2006; 86: 425-8.
Bouquerra R, Essais O, Sebai N et al. Prevalence and clinical aspects of superficial mycosis in hospitalized diabetic patients in Tunisia. Med Mal Infect 2004; 34: 201-5.
Dogra S, Kumar B, Bhansalo A, Chakrabarty A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol 2002; 41: 647-51.
Sürücüoğlu S, Özmen B, Gündüz K et al. The frequency of superficial fungal infection in patients with diabetes mellitus and its relation to level of HbAIC. Turkish J Endocrinol Metab 1998; 2: 21-3.
Eckhard M, laxgler A, Liersch J et al. Fungal foot infector in patients with diabetes mellitus- results of two independent investigators. Mycoses 2007; 50 (suppl): 14-9.
Breker D. Fungal nail infection. N Engl J Med 2009; 36: 2108-16.